New Delhi: Fact.MR, a market research and competitive intelligence provider, has revealed that the global cardiac POC testing devices market is expected to reach a valuation of US$ 1.9 billion by 2026, rising at a high CAGR of 6% over the forecast period (2022-2026).
Rising occurrence of cardiovascular disorders around the world is one of the key reasons propelling the growth of the global cardiac POC testing devices market. Cardiac POC testing is the result of advanced medical technology. These cutting-edge methods aid in early disease detection and improve cardiac health.
The number of deaths due to coronary artery disorders is on the rise, which is a cause for concern. Cardiac POC testing devices are gaining popularity due to their ability to diagnose the disease quickly and precisely. Growing public and private support for cardiac biomarker research, continuous clinical trials to find new cardiac biomarkers, the necessity to prevent heart illnesses, and rising awareness about early diagnosis are driving market expansion.
Medical diagnostic tests frequently entail cardiac POC testing devices. They also save time as compared to standard laboratory testing procedures. Additionally, these tools and kits are simple to use and ensure the security and contentment of the patient.
“Growing usage of cardiac POC testing devices by healthcare professionals, rising adoption of rapid & efficient medical tests, and increasing initiatives by government organizations to raise awareness among people about heart problems are factors driving market growth,” says a Fact.MR analyst
Key market participants are oriented toward the accuracy of the tests based on the detection of cardiac POC testing devices and are focused on attaining expansion via the development of novel product designs and new tests.
For instance, PTS Diagnostics recently disclosed a partnership with renowned healthcare contract sales firm MedPro Healthcare Sales Solutions.
Key manufacturers are concentrating on creating quick and accurate diagnostic tools to identify cardiovascular problems earlier. Major companies are working together to develop more advanced and portable testing solutions to make a mark in the industry.
For instance, St. Jude Medical, a manufacturer of cardiac devices, was acquired by Abbott Laboratories. The partnership aims to create a sizable number of novel medical devices focused on patients with cardiovascular problems.
Key Takeaways from Market Study
The global cardiac POC testing devices market is predicted to reach US$ 1.9 billion by 2026.
Market in Canada anticipated to increase at 6% CAGR over forecast period.
Demand for analyzers expected to rise at 5.3% CAGR from 2022 to 2026.
Market in Germany projected to increase at 5% CAGR through 2026.